Catalyst Wire Dossier Catalyst Wire Dossier

PCSK-9 inhibitors

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PCSK-9 inhibitors, covering 2025-05-30 to 2025-05-30. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter, Prospective, Randomized Controlled Trial to Evaluate the Efficacy of PCSK-9 Inhibitors in Delaying the Progression of Calcified Aortic Valve Disease [EARLY_Phase 1]

See pricing